Roche Diagnostics and its partner KlinRisk Inc have received the EU CE mark for the very first AI-based risk stratification tool that reliably assesses progressive decline in kidney function.
Tag Archive for: AI
British antibody specialist Alchemab Therapeutics Ltd has secured a US$32m Series A extension after it completing preclinical development of ATLX-1282 and starting a Phase I clinical trial.
Paris-based One Biosciences, a pioneering “techbio” company at the intersection of artificial intelligence and oncology, has announced a €15 million Series A funding round to accelerate the clinical application of its flagship technology.
Under a new partnership, Plectonic Biotech will use Sonrai’s AI-powered multi-omics platform to speed up development of its Logybody cancer treatment technology. The approach aims to cut side effects and improve precision.
The Hamburg-based company Indivumed has repositioned itself, sending a clear message with a recent change in leadership: A new chapter is beginning with the focus on discovering and developing novel therapeutic targets for innovative cancer therapies. |transkript spoke with Prof. Dr. Hartmut Juhl and Dr. Matthias Evers.
BioNTech is set to open a research centre for cancer therapy in the United Kingdom, much to the delight of the British government, which is helping pave the way with a substantial financial boost.
Only three weeks to go until Europe’s largest event for laboratory automation and drug screening. SLAS Europe 2025, organised by the Society for Laboratory Automation and Screening (SLAS), will take place in Hamburg from 20-22 May. In a series, European Biotechnology Magazine presents the 12 most innovative SMEs today: French Minos Biosciences SAS.
The much-discussed digital transformation in the healthcare sector is in full swing. European Biotechnology spoke with Dr. Sabrina Graf, COO of the globally active Tenthpin Group, about how the right software can improve quality management, keep the system landscape lean, and safe both, time and money.
University of Oxford spinout Brainomix Ltd has closed a £14m Series C round to advance its commercial expansion in the US. Funding will also support clinical uptake of its AI imaging technology in stroke and lung fibrosis.
The Dutch-Swiss company with operations also in Zurich, Switzerland, has raised US$73m in a Series B and will continue to expand its AI research, sales, and operations teams. The new announcement comes around a year after raising €21.92m in a Series A funding round.
Tag Archive for: AI
Artificial intelligence (AI) is no longer just a technological trend; it is a transformative force that is accelerating the transition from fossil fuels to renewable carbon sources in the chemical and materials industry. This represents one of the greatest industrial challenges since the beginning of the industrial revolution, requiring the most advanced digital solutions available. AI is emerging as the key enabler of this transformation.
Recognising the transformative power of artificial intelligence, nova-Institute is actively shaping this development by holding this conference. The AI Circular Economy Conference will bring together all relevant stakeholders to discuss the need for AI solutions in a circular economy in the chemistry and materials sector and to match these needs with technical solutions from scientists and developers.
Featuring top experts in AI development, chemical and plastics manufacturing, biotechnology, agriculture, recycling and sustainability, this interdisciplinary event will explore the latest developments in the field.
Topics include, but are not limited to, the following:
• High-tech innovators are delivering cutting-edge AI solutions for science and industry.
• Chemical and plastics producers are using AI to innovate more quickly, efficiently, and sustainably.
• The agricultural and biomass sectors are using AI in precision farming to increase yields, lower the environmental impacts and close the loop on material flows.
• Cutting-edge applications of AI, including AI-assisted modelling of CCU processes and catalysts, optimisation of CO2 capture, and the design of novel chemical pathways such as those involving electrochemistry.
• Use of AI for process control and optimisation in depolymerisation, advanced waste stream sorting and feedstock analysis, as well as quality assurance of recycled materials.
Venue Information:
Maternushaus
Cologne, Germany (and online)
4-5 March 2026
Contact:
Kristijan Mršić
kristijan.mrsic@nova-institut.de


Roche Diagnostics International
Alchemab Therapeutics Ltd
Jovanche Vitanovski/123rf.com
Max Kratzer / Plectonic
Indivumed GmbH
BioNTech
Minos Biosciences SAS
Tenthpin Group
Brainomix Ltd.
Cradle.bio